Applied Imaging and StemCell renew cancer pact
This article was originally published in Clinica
Executive Summary
Applied Imaging has renewed its exclusive supply agreement with StemCell Technologies to use the latter's non-magnetic cell separation technology in the isolation of circulating tumour cells in the blood of cancer patients.